Concepedia

Jordan S. Fridman

JS

35

Publications

8.9K

Citations

28

H-Index

1998

Active since

Affiliations

Incyte (United States)(Current)

Cold Spring Harbor Laboratory

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

University of California, San Francisco

Jordan S. Fridman is an author at Incyte (United States) specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

1998–2017

35

Publications

35

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis

Srđan Verstovšek, Hagop M. Kantarjian, Ruben A. Mesa et al. · New England Journal of Medicine · 2010 · 1.2K citations · Full text

A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy

Clemens A. Schmitt, Jordan S. Fridman, Meng Yang et al. · Cell · 2002 · 1K citations · Full text

, , +11

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

Hans-Guido Wendel, Elisa de Stanchina, Jordan S. Fridman et al. · Nature · 2004 · 946 citations

, , +8

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

Alfonso Quintás‐Cardama, Kris Vaddi, Phillip Liu et al. · Blood · 2010 · 813 citations

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

Xiangdong Liu, Niu Shin, Holly K. Koblish et al. · Blood · 2010 · 552 citations · Full text

Rows per page

1–5 of 35